These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The role of metabolic acidosis in the pathogenesis of renal osteodystrophy. Kraut JA Adv Ren Replace Ther; 1995 Jan; 2(1):40-51. PubMed ID: 7614335 [TBL] [Abstract][Full Text] [Related]
24. [Osteodystrophy in children with chronic renal insufficiency in dialysis therapy]. Bartolozzi G; Pela I; Lavoratti GC; Bettucci E; Sirovich A; Pierattelli M; Materassi M Pediatr Med Chir; 1982; 4(1-2):65-9. PubMed ID: 6287442 [TBL] [Abstract][Full Text] [Related]
27. The renal bone diseases in children treated with dialysis. Sanchez CP; Salusky IB Adv Ren Replace Ther; 1996 Jan; 3(1):14-23. PubMed ID: 8620364 [TBL] [Abstract][Full Text] [Related]
28. Diseases of the urinary system. renal osteodystrophy. Hosking DJ Br Med J; 1977 Jul; 2(6079):110-2. PubMed ID: 871770 [No Abstract] [Full Text] [Related]
29. [Management of renal osteopathy in patients with chronic dialysis]. Kiss D; Brunner FP Schweiz Med Wochenschr; 1996 Oct; 126(42):1792-8. PubMed ID: 8966512 [TBL] [Abstract][Full Text] [Related]
30. Adynamic bone and chronic renal failure: an overview. Cannata AndÃa JB Am J Med Sci; 2000 Aug; 320(2):81-4. PubMed ID: 10981480 [TBL] [Abstract][Full Text] [Related]
31. The pathophysiology and management of renal bone disease in dialysis patients. Meers C; Morton AR; Toffelmire EB CANNT J; 1999; 9(2):24-9, 32-8; quiz 30-1, 39-40. PubMed ID: 11778255 [TBL] [Abstract][Full Text] [Related]
32. Calcium and phosphorus metabolism in chronic uremia. Fiaschi E; Mioni G; Maschio G; D'Angelo A; Ossi E Nephron; 1975; 14(2):163-80. PubMed ID: 1093055 [TBL] [Abstract][Full Text] [Related]
33. Management of renal osteodystrophy in children. Tasic V Turk J Pediatr; 2005; 47 Suppl():13-8. PubMed ID: 15884662 [TBL] [Abstract][Full Text] [Related]
34. [Renal osteodystrophy (I)]. Covic A; Florea L; Ungureanu C; Covic M Rev Med Chir Soc Med Nat Iasi; 2000; 104(3):31-5. PubMed ID: 12089922 [TBL] [Abstract][Full Text] [Related]
35. [Physiopathology of renal osteodystrophy. I. Patients with kidney failure without dialysis]. Fournier A; Bordier P; Weil B; Safar M; Idatte JM Presse Med (1893); 1971 Oct; 79(45):2017-21. PubMed ID: 5119047 [No Abstract] [Full Text] [Related]
36. Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy. Goodman WG; Ramirez JA; Belin TR; Chon Y; Gales B; Segre GV; Salusky IB Kidney Int; 1994 Oct; 46(4):1160-6. PubMed ID: 7861712 [TBL] [Abstract][Full Text] [Related]
37. Effects of treatment of renal osteodystrophy on bone histology. Malluche HH; Mawad H; Monier-Faugere MC Clin J Am Soc Nephrol; 2008 Nov; 3 Suppl 3(Suppl 3):S157-63. PubMed ID: 18988701 [TBL] [Abstract][Full Text] [Related]
38. Development of renal bone disease. Ferreira A Eur J Clin Invest; 2006 Aug; 36 Suppl 2():2-12. PubMed ID: 16884393 [TBL] [Abstract][Full Text] [Related]
39. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
40. The role of phosphate and other factors on the pathogenesis of renal osteodystrophy. Slatopolsky E; Rutherford WE; Martin K; Hruska K Adv Exp Med Biol; 1977; 81():467-75. PubMed ID: 899937 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]